Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) CFO Houte Hans Van sold 2,845 shares of the company’s stock in a transaction on Thursday, July 30th. Houte Hans Van also recently made the following trade(s):Get Nurix Therapeutics alerts:On Tuesday, May 5th, Houte Hans Van sold 14,055 shares of Nurix Therapeutics stock. Nurix Therapeutics Stock PerformanceNASDAQ:NRIX traded down $0.02 on Thursday, reaching $23.58. The business’s 50-day moving average price is $20.31 and its two-hundred day moving average price is $17.78. See AlsoReceive News & Ratings for Nurix Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nurix Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.